Supernus (SUPN) | Stock Overview & Key Data
Supernus Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $61.25 on June 25, 2018
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supernus
SUPN
|
2.83B Mid-cap | -1.39% | -11.27% | -12.65% | -7.23% | -11.34% | 38.65% | 31.51% | 38.39% | 149.21% | 643.89% | 643.89% |
|
Zoetis
ZTS
|
49.75B Large-cap | 0.16% | 3.42% | -31.08% | -32.94% | -36.81% | -51.58% | -53.40% | -57.08% | 71.34% | 156.59% | 156.59% |
|
Haleon Plc - ADR
HLN
|
42.40B Large-cap | 2.02% | 1.23% | -13.29% | -7.73% | -9.30% | -16.01% | 8.43% | 23.21% | 23.21% | 23.21% | 23.21% |
|
Alkermes plc
ALKS
|
5.55B Mid-cap | 4.50% | 18.36% | 58.43% | 57.47% | 56.97% | 48.44% | 37.56% | 81.33% | 7.03% | 166.59% | 137.55% |
|
Lantheus Holdings
LNTH
|
5.39B Mid-cap | 4.66% | 11.46% | 33.34% | 57.23% | 55.60% | 34.29% | 18.41% | 324.53% | 3,800.00% | 1,525.51% | 1,525.51% |
|
Amneal
AMRX
|
4.15B Mid-cap | 18.45% | 36.13% | 36.01% | 30.34% | 28.28% | 109.03% | 497.79% | 211.54% | 10.20% | 10.20% | 10.20% |
Ownership & Short Interest
Calculate Your Supernus Investment Returns
Long-Term Investment Performance Analysis
Supernus stock price in Jul 2016 was $21.03, A $1,000.00 lump sum investment in Supernus made 9 years ago would be worth approximately $2,085.59 today, representing a strong return of 108.56%. This translates to an annualized return (CAGR) of 7.70%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SUPN's 52-week high and low?
- In the last 52 weeks, Supernus reached a high of $59.68 (on February 25, 2026) and a low of $30.83 (on June 25, 2025).
- What is the market cap and P/E ratio for SUPN?
- Curious about Supernus's size and valuation? Its market capitalization stands at 2.83B. When it comes to valuation, the P/E ratio (trailing twelve months) is 40.66, and the forward P/E (looking ahead) is 11.64.
- Does SUPN pay dividends? If so, what's the yield?
- As for dividends, Supernus isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Supernus's main competitors or similar companies to consider before investing?
When looking at Supernus, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS49.75B Healthcare Drug Manufacturers - Specialty & Generic -51.58% -53.40% Haleon Plc - ADR
HLN42.40B Healthcare Drug Manufacturers - Specialty & Generic -16.01% 8.43% Alkermes plc
ALKS5.55B Healthcare Drug Manufacturers - Specialty & Generic 48.44% 37.56% Lantheus Holdings
LNTH5.39B Healthcare Drug Manufacturers - Specialty & Generic 34.29% 18.41% Amneal
AMRX4.15B Healthcare Drug Manufacturers - Specialty & Generic 109.03% 497.79% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Supernus Pharmaceuticals Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Supernus's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -3.68%, the Debt to Equity ratio from the most recent quarter is 3.86, and its Gross Profit Margin stands at 89.13%.
- What is the recent revenue and earnings growth for SUPN?
- Looking at Supernus's growth, its revenue over the trailing twelve months (TTM) was $719M. Compared to the same quarter last year (YoY), quarterly revenue grew by 21.50%, and quarterly earnings saw a YoY growth of 21.48%.
- How much of SUPN stock is held by insiders and institutions?
- Wondering who owns Supernus stock? Company insiders (like executives and directors) hold about 4.34% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 105.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.